Indication
Neurologic Manifestations
6 clinical trials
8 products
Clinical trial
An Open-Label, Extension Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of QR-110 in Subjects With Leber's Congenital Amaurosis (LCA) Due to the c.2991+1655A>G Mutation (p.Cys998X) in the CEP290 GeneStatus: Terminated, Estimated PCD: 2022-10-03
Product
QR-110Clinical trial
A Multi-Center, Phase II, Randomized, Double-Blind, Prospective, Active Placebo- Controlled Trial of Sub-Anesthetic Intravenous Infusion of Ketamine to Treat Levodopa- Induced Dyskinesia in Subjects With Parkinson's DiseaseStatus: , Estimated PCD: 2023-12-30
Product
MidazolamProduct
KetamineClinical trial
Nummular Headache Iberian Study on the Treatments and Outcomes in Real-World SettingStatus: Recruiting, Estimated PCD: 2024-12-31
Product
Clinical evaluationClinical trial
Clinical Effectiveness and Safety of Intraoperative Methadone in PatientsStatus: Completed, Estimated PCD: 2023-08-15
Product
MethadoneProduct
MorphineClinical trial
Gender Differences in Stroke With COVID-19: Epigenetic and Biochemical Study of ACE2 Receptor and Relationship With Rehabilitative OutcomeStatus: Completed, Estimated PCD: 2022-12-16
Product
Epigenetic AnalysesClinical trial
A Double Blind, Placebo Controlled, Fixed-Flexible Dose Clinical Trial of Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi SyndromeStatus: Recruiting, Estimated PCD: 2024-01-18
Product
Guanfacine